| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 30.60▼ | 30.73▼ | 30.99▼ | 32.47▼ | 29.31▲ |
| MA10 | 30.71▼ | 31.28▼ | 31.36▼ | 32.08▼ | 26.59▲ |
| MA20 | 31.20▼ | 31.59▼ | 32.48▼ | 28.22▲ | 22.37▲ |
| MA50 | 31.87▼ | 32.79▼ | 32.92▼ | 25.42▲ | 15.09▲ |
| MA100 | 32.70▼ | 31.95▼ | 28.97▲ | 21.44▲ | 13.83▲ |
| MA200 | 32.00▼ | 27.59▲ | 26.23▲ | 15.67▲ | 14.43▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.032▼ | -0.111▼ | -0.271▼ | 0.202▲ | 0.900▲ |
| RSI | 33.345▼ | 34.522▼ | 37.300▼ | 59.303▲ | 72.435▲ |
| STOCH | 5.556▼ | 7.490▼ | 31.104 | 70.480 | 76.141 |
| WILL %R | -100.000▼ | -89.555▼ | -92.761▼ | -38.498 | -25.896 |
| CCI | -98.077 | -90.255 | -94.875 | 25.171 | 151.411▲ |
|
Monday, September 21, 2020 11:15 AM
Merck (NYSE:MRK) and Eisai (OTCPK:ESALY) announce new data from two clinical trials evaluating the combination of Keytruda (pembrolizumab) and Lenvima (lenvatinib) in patients with a range of cancers.
|
|
Monday, September 21, 2020 05:11 AM
Merck (NYSE:MRK) announces data presentations at ESMO on pipeline candidates vibostolimab (MK-7684), MK-4830 and MK-6482.Phase 1 study evaluating anti-TIGIT therapy vibostolimab, combined with ...
|
|
Monday, September 21, 2020 05:11 AM
Merck (NYSE:MRK) and the European Organisation for Research and Treatment of Cancer (EORTC) announce new and updated findings from the Phase 3 EORTC1325/KEYNOTE-054 trial evaluating KEYTRUDA, Merck’s ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/09/20 | 30.885 | 32.805 | 30.49 | 30.49 | 54,619 |
| 22/09/20 | 33.78 | 33.79 | 30.18 | 30.74 | 91,100 |
| 21/09/20 | 34.07 | 34.49 | 33.08 | 33.75 | 68,252 |
| 18/09/20 | 32.71 | 34.15 | 31.9287 | 34.15 | 104,175 |
| 17/09/20 | 33.81 | 33.98 | 30.05 | 33.24 | 120,800 |
| 16/09/20 | 32.17 | 34.656 | 32.17 | 33.13 | 66,100 |
| 15/09/20 | 33.79 | 34.085 | 31.50 | 32.30 | 79,200 |
| 14/09/20 | 34.00 | 34.928 | 32.85 | 33.82 | 126,200 |
| 11/09/20 | 30.01 | 33.15 | 29.50 | 33.15 | 391,200 |
| 10/09/20 | 26.15 | 26.15 | 25.72 | 26.06 | 65,000 |
|
|
||||
|
|
||||
|
|